XML 93 R83.htm IDEA: XBRL DOCUMENT v3.24.3
Supplemental Consolidating Data - Cash Flows (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:                
Net income $ 115,967 $ 215,406 $ 232,233 $ 196,103 $ 173,830 $ 301,829 $ 563,605 $ 671,762
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             119,568 112,592
Amortization of deferred loan origination costs             54,461 65,996
Amortization of financing origination fees             10,363 9,734
Provision for long-term employee benefits             (40,076) (50,373)
Employee benefit plan contributions and payments             (3,781) (2,668)
Stock compensation expense             39,820 64,538
Net change in wholesale finance receivables related to sales             (211,800) (392,817)
Provision for credit losses             175,017 170,496
Deferred income taxes             (1,815) (8,455)
Other, net             19,557 (19,738)
Changes in current assets and liabilities:                
Accounts receivable, net             (36,529) (72,084)
Finance receivables – accrued interest and other             2,325 2,366
Inventories, net             253,373 160,742
Accounts payable and accrued liabilities             (12,903) 14,453
Other current assets             (530) (19,777)
Total adjustments             367,050 35,005
Net cash provided by operating activities             930,655 706,767
Cash flows from investing activities:                
Capital expenditures             (140,424) (138,902)
Origination of finance receivables             (3,002,737) (3,162,957)
Collections on finance receivables             2,657,149 2,789,848
Other investing activities             (165) 878
Net cash used by investing activities             (486,177) (511,133)
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             495,856 1,446,304
Repayments of medium-term notes             0 (1,056,680)
Proceeds from securitization debt             1,145,211 1,045,547
Repayments of securitization debt             (782,161) (930,608)
Borrowings of asset-backed commercial paper             366,171 42,429
Repayments of asset-backed commercial paper             (195,709) (187,599)
Net (decrease) increase in unsecured commercial paper             (387,392) 43,523
Net increase in deposits             100,737 161,157
Dividends paid             (69,454) (72,775)
Repurchase of common stock             (359,810) (239,428)
Other financing activities             11 1,706
Net cash provided by financing activities             313,460 253,576
Effect of exchange rate changes on cash, cash equivalents and restricted cash             198 (8,415)
Net increase in cash, cash equivalents and restricted cash             758,136 440,795
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     1,648,811     1,579,177 1,648,811 1,579,177
Net (decrease) increase in cash, cash equivalents and restricted cash             758,136 440,795
Cash, cash equivalents and restricted cash, end of period 2,406,947     2,019,972     2,406,947 2,019,972
Reportable Legal Entities | Non-Financial Services Entities                
Cash flows from operating activities:                
Net income 59,441     352,629     414,535 739,888
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             112,605 105,824
Amortization of deferred loan origination costs             0 0
Amortization of financing origination fees             540 532
Provision for long-term employee benefits             (40,076) (50,373)
Employee benefit plan contributions and payments             (3,781) (2,668)
Stock compensation expense             38,234 61,642
Net change in wholesale finance receivables related to sales             0 0
Provision for credit losses             0 0
Deferred income taxes             3,347 147
Other, net             15,505 (15,606)
Changes in current assets and liabilities:                
Accounts receivable, net             (79,746) (312,549)
Finance receivables – accrued interest and other             0 0
Inventories, net             253,373 160,742
Accounts payable and accrued liabilities             (35,743) (10,440)
Other current assets             (23,008) (24,418)
Total adjustments             241,250 (87,167)
Net cash provided by operating activities             655,785 652,721
Cash flows from investing activities:                
Capital expenditures             (139,295) (135,768)
Origination of finance receivables             0 0
Collections on finance receivables             0 0
Other investing activities             (1,165) (1,622)
Net cash used by investing activities             (140,460) (137,390)
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             0 0
Repayments of medium-term notes               0
Proceeds from securitization debt             0 0
Repayments of securitization debt             0 0
Borrowings of asset-backed commercial paper             0 0
Repayments of asset-backed commercial paper             0 0
Net (decrease) increase in unsecured commercial paper             0 0
Net increase in deposits             0 0
Dividends paid             (69,454) (72,775)
Repurchase of common stock             (359,810) (239,428)
Other financing activities             11 1,706
Net cash provided by financing activities             (429,253) (310,497)
Effect of exchange rate changes on cash, cash equivalents and restricted cash             (171) (8,212)
Net increase in cash, cash equivalents and restricted cash             85,901 196,622
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     1,127,400     1,021,798 1,127,400 1,021,798
Net (decrease) increase in cash, cash equivalents and restricted cash             85,901 196,622
Cash, cash equivalents and restricted cash, end of period 1,213,301     1,218,420     1,213,301 1,218,420
Reportable Legal Entities | Financial Services Entities                
Cash flows from operating activities:                
Net income 56,504     43,523     149,037 131,842
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             6,963 6,768
Amortization of deferred loan origination costs             54,461 65,996
Amortization of financing origination fees             9,823 9,202
Provision for long-term employee benefits             0 0
Employee benefit plan contributions and payments             0 0
Stock compensation expense             1,586 2,896
Net change in wholesale finance receivables related to sales             0 0
Provision for credit losses             175,017 170,496
Deferred income taxes             (4,724) (8,764)
Other, net             4,085 (4,099)
Changes in current assets and liabilities:                
Accounts receivable, net             0 0
Finance receivables – accrued interest and other             2,325 2,366
Inventories, net             0 0
Accounts payable and accrued liabilities             53,591 257,748
Other current assets             12,295 4,645
Total adjustments             315,422 507,254
Net cash provided by operating activities             464,459 639,096
Cash flows from investing activities:                
Capital expenditures             (1,129) (3,134)
Origination of finance receivables             (5,671,416) (6,035,046)
Collections on finance receivables             5,136,239 5,276,887
Other investing activities             0 0
Net cash used by investing activities             (536,306) (761,293)
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             495,856 1,446,304
Repayments of medium-term notes               (1,056,680)
Proceeds from securitization debt             1,145,211 1,045,547
Repayments of securitization debt             (782,161) (930,608)
Borrowings of asset-backed commercial paper             366,171 42,429
Repayments of asset-backed commercial paper             (195,709) (187,599)
Net (decrease) increase in unsecured commercial paper             (387,392) 43,523
Net increase in deposits             100,737 161,157
Dividends paid             0 (200,000)
Repurchase of common stock             0 0
Other financing activities             1,000 2,500
Net cash provided by financing activities             743,713 366,573
Effect of exchange rate changes on cash, cash equivalents and restricted cash             369 (203)
Net increase in cash, cash equivalents and restricted cash             672,235 244,173
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     521,411     557,379 521,411 557,379
Net (decrease) increase in cash, cash equivalents and restricted cash             672,235 244,173
Cash, cash equivalents and restricted cash, end of period 1,193,646     801,552     1,193,646 801,552
Consolidating Adjustments                
Cash flows from operating activities:                
Net income 22     (200,049)     33 (199,968)
Adjustments to reconcile Net income to Net cash provided by operating activities:                
Depreciation and amortization             0 0
Amortization of deferred loan origination costs             0 0
Amortization of financing origination fees             0 0
Provision for long-term employee benefits             0 0
Employee benefit plan contributions and payments             0 0
Stock compensation expense             0 0
Net change in wholesale finance receivables related to sales             (211,800) (392,817)
Provision for credit losses             0 0
Deferred income taxes             (438) 162
Other, net             (33) (33)
Changes in current assets and liabilities:                
Accounts receivable, net             43,217 240,465
Finance receivables – accrued interest and other             0 0
Inventories, net             0 0
Accounts payable and accrued liabilities             (30,751) (232,855)
Other current assets             10,183 (4)
Total adjustments             (189,622) (385,082)
Net cash provided by operating activities             (189,589) (585,050)
Cash flows from investing activities:                
Capital expenditures             0 0
Origination of finance receivables             2,668,679 2,872,089
Collections on finance receivables             (2,479,090) (2,487,039)
Other investing activities             1,000 2,500
Net cash used by investing activities             190,589 387,550
Cash flows from financing activities:                
Proceeds from issuance of medium-term notes             0 0
Repayments of medium-term notes               0
Proceeds from securitization debt             0 0
Repayments of securitization debt             0 0
Borrowings of asset-backed commercial paper             0 0
Repayments of asset-backed commercial paper             0 0
Net (decrease) increase in unsecured commercial paper             0 0
Net increase in deposits             0 0
Dividends paid             0 200,000
Repurchase of common stock             0 0
Other financing activities             (1,000) (2,500)
Net cash provided by financing activities             (1,000) 197,500
Effect of exchange rate changes on cash, cash equivalents and restricted cash             0 0
Net increase in cash, cash equivalents and restricted cash             0 0
Cash, cash equivalents and restricted cash:                
Cash, cash equivalents and restricted cash, beginning of period     $ 0     $ 0 0 0
Net (decrease) increase in cash, cash equivalents and restricted cash             0 0
Cash, cash equivalents and restricted cash, end of period $ 0     $ 0     $ 0 $ 0